venture capital

R&D
LSX USA Jonah Comstock and Eloise McLennan Wrapup

Investment outlook: Key takeaways from LSX USA

Investment and strategic partnerships are the lifeblood of innovation in healthcare, driving groundbreaking discoveries and accelerating the development of life-changing therapies.

News
Regeneron launches $500m venture capital arm

Regeneron launches $500m venture capital arm

Regeneron has formed a corporate venture capital unit with $100 million a year to invest over the next five years in “biopharmaceutical, healthcare, and health technology”